Researchers assess cognitive impairment in patients with breast cancer
A recent analysis of published studies estimates that one-quarter of adults with breast cancer have cognitive impairment before starting therapy. The analysis, which is published in Psycho-Oncology, also found that many patients' cognitive function declines after receiving chemotherapy, endocrine therapy, and/or hormone therapy for breast cancer.
"Our results suggest that cancer-related and personal factors may make a significant contribution to cognitive functioning," said lead author Aicha Dijkshoorn, of the University Medical Center Utrecht, in the Netherlands.
The ...






